B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Bi 2536

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bi 2536, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

su
68 shared targets
pha
50 shared targets
alvocidib
51 shared targets
ruxolitinib
44 shared targets
gsk
30 shared targets
kw
73 shared targets
bosutinib
57 shared targets
fedratinib
71 shared targets
ruboxistaurin
40 shared targets
tae
71 shared targets
Loading evidence profile...

This evidence profile for Bi 2536 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.